Himanshu S Gadgil

Title: Himanshu S Gadgil: Innovator in Antibody Production

Introduction

Himanshu S Gadgil is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of biotechnology, particularly in the production of recombinant antibodies. His innovative work has led to advancements in the methods used for enhancing the recovery of IgG proteins.

Latest Patents

Himanshu holds a patent titled "Methods for refolding of recombinant antibodies." This invention is directed towards methods that increase the enrichment or recovery of preferred forms of IgG proteins. Specifically, it involves subjecting preparations of recombinant IgG proteins to a reduction/oxidation coupling reagent and optionally a chaotropic agent. This patent showcases his expertise in biochemistry and protein engineering.

Career Highlights

Himanshu is currently employed at Amgen Inc., a leading biotechnology company known for its innovative therapies. His role at Amgen allows him to work on cutting-edge research and development projects that aim to improve healthcare outcomes. His contributions to the field have been recognized by his peers and the scientific community.

Collaborations

Throughout his career, Himanshu has collaborated with esteemed colleagues, including Thomas M Dillon and Douglas Rehder. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Himanshu S Gadgil is a prominent figure in the biotechnology sector, with a focus on improving antibody production methods. His patent and work at Amgen reflect his commitment to advancing scientific knowledge and healthcare solutions. His contributions continue to impact the field positively.